Loading clinical trials...
Loading clinical trials...
An Open-label Study to Evaluate the Effectiveness and Safety of EZYPRO® in Atrial Fibrillation Detection in Nearly Embolic Stroke of Undetermined Source (ESUS) Patient
Conditions
Interventions
EZYPRO® ECG Recorder
Locations
1
Taiwan
National Taiwan University Hospital
Taipei, Taiwan
Start Date
March 28, 2022
Primary Completion Date
March 1, 2023
Completion Date
December 1, 2023
Last Updated
May 10, 2022
NCT05147792
NCT06935591
NCT05963698
NCT04947657
NCT03546374
NCT06686485
Lead Sponsor
Sigknow Biomedical Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions